In less than a decade, Samsung Biologics has gained the reputation as one of the most trusted CDMO partners with an impeccable global track record. In an increasingly competitive environment, working with the right CDMO is vital for successful drug lifecycle management. We now serve more than half of the world’s leading biopharmaceutical companies, sharing their mission to expedite patient access to life-saving biologics.
Our modular expandable facility, located in South Korea's biopharmaceutical hub, is currently the world’s largest and most advanced for biologics development and manufacturing. We credit this success to our unwavering commitment: to deliver the highest quality biologics as promptly and safely as possible.